Skip to main content

Find Clinical Trials

Home
Conditions
Multiple Sclerosis

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

296 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Recruiting

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

NCT06733922

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Charcot-Marie-Tooth disease, Type 1F, +7 more
Locations: Novartis Investigative Site Calgary, Alberta, Canada

Novartis Investigative Site Calgary, Alberta, Canada

Novartis Investigative Site Edmonton, Alberta, Canada

Novartis Investigative Site Burnaby, British Columbia, Canada

View all 14 locations

View Trial Details

Recruiting

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

NCT06864936

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: University of Maryland, Baltimore Baltimore, Maryland, United States

View Trial Details

Recruiting

The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis

NCT06599307

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations: Kasr Alainy Multiple Sclerosis Unit (KAMSU), Cairo University hospitals. Giza, Giza Governorate, Egypt

View Trial Details

Recruiting

Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients

NCT07392879

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +13 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Recruiting

Effects of Ublituximab on Motor Functions in Multiple Sclerosis

NCT06629428

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations: Georgia State University Atlanta, Georgia, United States

Atlanta Neuroscience Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies

NCT06586177

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Heinrich-Heine University, Duesseldorf Düsseldorf, Germany

View Trial Details

Recruiting

TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

NCT03910738

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: CHU de Besançon Besançon, France

CHU Nancy Nancy, France

Hôpital Pitié-Salpêtrière Paris, France

CHU de Rennes/Pontchaillou Rennes, France

View Trial Details

Recruiting

Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis

NCT03401879

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +9 more
Locations: Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria

View Trial Details

Recruiting

Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis

NCT06389968

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +9 more
Locations: Technical University of Munich Munich, Bavaria, Germany

View Trial Details

Recruiting

Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

NCT06663111

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Haukeland University Hospital, Deparment of medical biochemistry and pharmacology Bergen, Vestland, Norway

View Trial Details